Levels of macrophage migration inhibitory factors are associated with disease activity and possible complications of membranous nephropathy

  • Gao, S., Cui, Z. & Zhao, MH Activation of complement C3a and C3a receptors mediates podocyte damage in the mechanism of primary membranous nephropathy. Jam. Soc. Nephrol. 331742–1756 (2022).

    Google Scholar

  • Ronco, PM et al. membranous nephropathy. Nat. Rev. Say. Primers. seven1 (2021).

    Google Scholar

  • Beck, L.H. et al. M-type phospholipase A2 receptor as a target antigen in idiopathic membranous nephropathy. N.Engl. J.Med. 36111–21 (2009).

    CAS PubMed PubMed Central Google Scholar

  • Tomas, New Mexico et al. Thrombospondin type 1 containing domain 7A in idiopathic membranous nephropathy. N.Engl. J.Med. 3712277-2287 (2014).

    PubMed PubMed Central Google Scholar

  • Xu, ZF, Chen, L., Xiang, HL, Zhang, C., and Xiong, J. Advances in the pathogenesis of idiopathic membranous nephropathy. Kidney Say. 61–16 (2022).

    Google Scholar

  • Bruchfeld, A., Wendt, M. & Miller, EJ Macrophage migration inhibitory factor in clinical renal failure. Front. Immunol. seven8 (2016).

    PubMed PubMed Central Google Scholar

  • Strusmann, T. et al. Platelets are a hitherto unrecognized source of MIF. J. Thromb. Hemost. 1101004-1013 (2013).

    CAS Google Scholar

  • Lang, T., Foote, A. & Lee, JPW MIF: Implications in the pathoetiology of systemic lupus erythematosus. Front. Immunol. 6577 (2015).

    ADS PubMed PubMed Central Google Scholar

  • Joshua, B., Shan, S. & Yousef, A. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development. Expert advice. The. Targets 201463-1475 (2016).

    Google Scholar

  • Stanislava, SG, Tamara, S., Dorde, M. & Ivana, S. MIF and insulin: lifelong companions from common genesis to common pathogenesis. Cytokine 125154792 (2020).

    Google Scholar

  • Angelina, O., Deng, C. & Frank, JD Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation. Drug discovery. Today 261728-1734 (2021).

    Google Scholar

  • Price, S. Connective tissue diseases: Small molecule MIF inhibitor protects lupus-prone mice from kidney disease. Nat. Rev. Rheumatol. seven70 (2011).

    Google Scholar PubMed

  • Leung, JC et al. Anti-macrophage migration inhibitory factor reduces expression of transforming growth factor-β1 in experimental IgA nephropathy. Nephrol. Dial. Transplant. 191976-1985 (2004).

    CAS PubMed Google Scholar

  • Nachman, PH, Jennette, JC, and Falk, RJ Membranous glomerulopathy. In The Kidney of Brenner and Rector 9th ed. (ed. Brenner, BM) 1121–1131 (Saunders, 2012).

    Google Scholar

  • Ives, A. et al. Macrophage migration inhibitory factor promotes migration of dendritic cells through CD74 and activation of the Src/PI3K/myosin II pathway. FASB J. 351 (2021).

    Google Scholar

  • Ruyi, L. et al. The role of macrophage migration inhibitory factor (MIF) in asthmatic airway remodeling. Immune Asthma Allergy. 1388-105 (2021).

    Google Scholar

  • Santoscoy, AG et al. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from southern Mexico. Mol. Broom. Genome. Med. 8e1037 (2020).

    Google Scholar

  • Sakurai, N. et al. Influence of MIF polymorphisms on CDKN2A CpG island hyper-methylation in patients with ulcerative colitis. BMC Med. Ethics. 211–9 (2020).

    Google Scholar

  • Fabian, B. et al. Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis. Clin. Transl. Immunol. sevene1042 (2018).

    Google Scholar

  • Gamez, INM et al. Evaluation of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study. Biomark. Res. 81–12 (2020).

    Google Scholar

  • Thierry, C. & Richard, B. Macrophage migration inhibitory factor (MIF): a counter-regulator of glucocorticoids within the immune system. Crit. Rev. Immunol. 37359–370 (2017).

    Google Scholar

  • Deepa, R. et al. Targeting Distinct D-DT and MIF Tautomerase Sites with a Single Molecule for Inhibition of Pulmonary Neutrophil Recruitment. FASB J. 284961–4971 (2014).

    Google Scholar

  • Rice, EK et al. Induction of MIF synthesis and secretion by tubular epithelial cells – A new action of angiotensin II. Jam. Soc. Nephrol. 13348A (2002).

    Google Scholar

  • Fiona, UK et al. Urinary macrophage migration inhibitory factor reflects the severity of kidney damage in human glomerulonephritis. Jam. Soc. Nephrol. 137-13 (2002).

    Google Scholar

  • Zwiech, R. Urinary Excretion of Macrophage Migration Inhibitory Factor Revisited – MIF a Strong Predictor of Immunosuppressive Treatment Outcome in Patients With Primary Proliferative Glomerulonephritis. BMC Immunol. 1647 (2015).

    PubMed PubMed Central Google Scholar

  • Stojanovic, T., Saksida, S. & Stosic, G. Beta cell function: the role of macrophage migration inhibitory factor. Immunol. Res. 5281–88 (2012).

    CAS PubMed Google Scholar

  • Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 365756–759 (1993).

    ADS CAS PubMed Google Scholar

  • Yong, JW et al. Targeting macrophage migration inhibitory factor in acute pancreatitis and pancreatic cancer. Front. Pharmacol. 12638950 (2021).

    Google Scholar

  • Akinobu, O. et al. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI and ATF4-dependent mechanisms. A m. J. Physiol. Kidney physiol. 313767–780 (2017).

    Google Scholar

  • Subbanaya, T. et al. An integrated macrophage migration inhibitory factor signal transduction network. J. Common cell. Signal. ten165-170 (2016).

    PubMed PubMed Central Google Scholar

  • Roger, T., Glauser, MP & Calandra, T. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. Endotoxin Res. seven456–460 (2001).

    CAS Google Scholar

  • Barbour, SJ et al. The disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 81190-195 (2012).

    Google Scholar PubMed

  • Zou, PM, Li, H., Cai, JF & Chen, ZJ A cohort study of the incidence and risk factors for thromboembolic events in patients with idiopathic membranous nephropathy. Chin. Med. Science. J 3391–99 (2018).

    Google Scholar PubMed

  • Chatterjee, M. Macrophage migration inhibitory factor limits platelet activation-induced apoptosis via CXCR7-dependent Akt signaling. Circ. Res. 115939–949 (2014).

    CAS PubMed Google Scholar

  • Strusmann, T. et al. Platelets are a hitherto unrecognized source of MIF. Thromb. Hemost. 1101004-1013 (2013).

    CAS PubMed Google Scholar

  • Tadamichi, S. et al. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J. Biol. Chem. 27913729–13737 (2004).

    Google Scholar

  • Taniguchi, Y., Yorioka, N., Yamashita, K., Masaki, T., and Yamakido, M. Macrophage migration inhibitory factor in IgA nephropathy. Kidney Int. 542245–2246 (1998).

    CAS PubMed Google Scholar

  • Tesch, GH et al. Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. Jam. Soc. Nephrol. 9417–424 (1998).

    CAS PubMed Google Scholar

  • Lan, HY et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 57499-509 (2000).

    CAS PubMed Google Scholar

  • L’Imperio, V. et al. The MALDI-MSI pilot study highlights glomerular deposits of macrophage migration inhibitory factor as a possible indicator of treatment response in membranous nephropathy. Proteome. Clin. Appl. 13e1800019 (2019).

    Google Scholar

  • About Hector Hedgepeth

    Check Also

    Folbigg’s life and advances in genetic research

    New South Wales will conduct a second inquiry into Kathleen Folbigg’s convictions. At the center …